Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Journal:
Nature Medicine
Published:
DOI:
10.1038/s41591-020-01193-6
Affiliations:
20
Authors:
32
Institutions Authors Share
Indiana University (IU), United States of America (USA)
8.000000
0.25
Riley Hospital for Children, IU Health, United States of America (USA)
7.500000
0.23
NIH NCI Center for Cancer Research (CCR), United States of America (USA)
3.000000
0.09
The University of Alabama at Birmingham (UAB), United States of America (USA)
3.000000
0.09
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)
1.500000
0.05
Children's Hospital of Philadelphia (CHOP), United States of America (USA)
1.000000
0.03
Children's National Health System, United States of America (USA)
1.000000
0.03
New York University (NYU), United States of America (USA)
1.000000
0.03
Ann and Robert H. Lurie Children's Hospital of Chicago, NU, United States of America (USA)
1.000000
0.03
Washington University in St. Louis (WUSTL), United States of America (USA)
1.000000
0.03
Massachusetts General Hospital (MGH), United States of America (USA)
1.000000
0.03
USC Children's Hospital Los Angeles (CHLA), United States of America (USA)
1.000000
0.03
Johns Hopkins University (JHU), United States of America (USA)
1.000000
0.03
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
0.500000
0.02
Boston Children's Hospital (BCH), United States of America (USA)
0.500000
0.02